fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Aurobindo Pharma Ltd

Aurobindo Pharma Ltd

Updated on May 13, 2019

Stock/Share Code - AUROPHARMA

Aurobindo Pharma is engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

Below is the details of AUROPHARMA Aurobindo Pharma Ltd

Market Cap₹41,720 Cr.
Current Price ₹670.45 as on 17 May 19
52 Week High / Low Price₹830 / ₹527.05
Face Value₹1
Stock P/E30.28
Book Value₹180.71
Dividend Yield0.35 %
ROCE19.02 %
ROE19.68 %
Sales Growth (3yrs)8.37 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has a good return on equity (ROE) track record: 3 Years ROE 22.46%
Cons: Promoter's stake has decreased Company might be capitalizing the interest cost

Aurobindo Pharma Ltd Price Chart

Aurobindo Pharma Ltd Price Chart

Aurobindo Pharma Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Piramal Enterp. ₹2,132.8 8.18 ₹42,817.87 Cr. 1.05 ₹603.98 Cr. 23.03 22.07 3489.08 8.85
2. Sun Pharma.Inds. ₹148.3 22.89 ₹106,806.4 Cr. 0.45 ₹1,461.03 Cr. 310.00 16.34 7740.19 10.41
3. Aurobindo Pharma 17.77 ₹41,719.55 Cr. 0.35 ₹712.22 Cr. 22.97 21.53 5269.67 22.85
4. Cadila Health. ₹249.65 16.48 ₹32,626.67 Cr. 1.10 ₹510.7 Cr. -6.00 9.75 3577.90 18.28
5. Dr Reddy's Labs ₹2,745 24.73 ₹43,701.41 Cr. 0.76 ₹500.3 Cr. 65.28 0.80 3864.60 7.75
6. Cipla ₹544.15 32.21 ₹44,680.04 Cr. 0.54 ₹332.2 Cr. -17.06 2.39 4007.54 9.64
7. Aurobindo Pharma 30.28 ₹41,719.55 Cr. 0.35 ₹463.51 Cr. 4.32 20.91 3248.10 19.02
8. Strides Pharma ₹414.1 4.39 ₹3,769.14 Cr. 0.47 ₹293.42 Cr. 234.73 6.10 794.50 16.15

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Aurobindo Pharma Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018
Sales2,4472,4302,4102,5212,4202,1883,0742,6862,3552,5593,1703,248
YOY Sales Growth %20.07%9.46%8.82%4.98%-1.12%-9.93%27.54%6.54%-2.7%16.93%3.14%20.91%
Expenses1,8431,8631,8171,8871,8401,7002,0352,0221,8772,1622,5632,650
Material Cost %46.05%48.63%49.37%47.35%46.5%44.92%39.83%46.69%46.77%51.48%50.63%51.89%
Employee Cost %8.73%9.24%9.11%9.15%10.43%11.87%8.83%10.54%13.48%12.48%10.47%10.77%
Operating Profit6045665936345804891,039664478397607598
OPM %25%23%25%25%24%22%34%25%20%16%19%18%
Other Income2421352951122934634137
Interest16141210910121317243141
Depreciation67707171738390909294101109
Profit before tax545503545582549407966595375282479585
Tax %24%22%23%24%17%24%22%25%18%20%21%21%
Net Profit413391419441455307753444308225381464
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales1,8672,2762,7493,1954,1304,2775,4247,1088,0699,1589,60710,27011,332
Sales Growth %36.26%21.93%20.8%16.23%29.24%3.57%26.81%31.06%13.51%13.5%4.91%6.9%%
Expenses1,5971,9172,5002,4973,1733,7044,4665,1875,8166,7057,2157,6009,252
Material Cost %62.57%59.58%59%54.76%53.29%58.89%55.51%49.01%46.81%46.85%48.37%44.43%%
Manufacturing Cost %10.82%11.06%9.91%9.97%10.34%11.42%11.06%9.37%9.69%9.8%9.83%10.35%%
Employee Cost %5.91%6.41%6.34%7.18%7.35%8.51%7.95%7.23%8.29%8.81%9.65%11.02%%
Other Cost %6.23%7.16%15.66%6.25%5.84%7.78%7.81%7.36%7.29%7.76%7.25%8.2%%
Operating Profit2703592506989575739581,9222,2532,4532,3922,6702,080
OPM %14%16%9%22%23%13%18%27%28%27%25%26%18%
Other Income1091197517229-30027736518711881150
Interest76598163552682502891322294553113
Depreciation72758295125143171186245263286355395
Profit before tax231345161712805-1385631,5191,9402,1482,1792,3431,721
Tax %1%16%20%26%26%69%12%23%22%24%22%23%
Net Profit229291129526594-434961,1721,5161,6271,7071,8131,378
EPS in Rs4.255.352.319.3510.040.008.3919.8525.5427.8028.7330.18
Dividend Payout %6%6%19%5%10%-68%9%7%9%9%9%8%

Compounded Sales Growth

  • 10 Years:: 16.26%
  • 5 Years:: 13.62%
  • 3 Years:: 8.37%
  • TTM:: 9.29%

Compounded Profit Growth

  • 10 Years:: 20.08%
  • 5 Years:: 29.65%
  • 3 Years:: 6.09%
  • TTM:: -29.70%

Return on Equity

  • 10 Years:: 23.79%
  • 5 Years:: 25.22%
  • 3 Years:: 22.46%
  • TTM:: 19.68%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Sep 2018
Share Capital27272728292929292959595959
Equity Capital26.6726.8826.8827.8629.1129.1129.1229.1529.258.5258.5958.59
Reserves9031,1941,2941,8862,5402,4642,9103,9835,3306,8078,3789,92410,529
Borrowings1,9761,7562,1151,9452,3182,7942,7822,9253,2854,1653,0543,7194,911
Other Liabilities4335386177519718691,2461,6571,6101,7951,8662,4782,280
Trade Payables284.08354.82415.11514.27750.92610.15927.71276.581233.031423.661366.531815.431797.3
Total Liabilities3,3393,5144,0534,6105,8596,1566,9678,59410,25412,82713,35616,18017,780
Fixed Assets7128278731,0451,3501,6272,0121,9382,1902,5683,2123,3934,137
Gross Block945.941134.481261.731526.881955.172363.272907.493008.823507.542830.783758.184292.18
Accumulated Depreciation233.46307.4388.86481.54605.28736.53895.581070.881317.53262.65546.56899.21
CWIP1831252864995375581662042277429071,144634
Investments2032882693714936297088731,0131,1831,6821,9682,092
Other Assets2,2412,2742,6252,6943,4793,3434,0815,5806,8248,3337,5569,67610,916
Inventories547.28651.23735.52944.821261.021219.261431.731711.812145.052431.62433.623409.233808.77
Trade receivables624.41798.971105.671151.351480.291426.281730.592970.123708.944380.973773.634477.445520.9
Cash Equivalents500.07239.3286.944.56122.2114.01114.579.7211.13330.8133.64245.971.34
Loans n Advances568.82584.78696.6593.67418.79504.4496.65408.06511.87899.07995.961234.83151.92
Total Assets3,3393,5144,0534,6105,8596,1566,9678,59410,25412,82713,35616,18017,780

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity4910553462455046253285902,457914
Profit from operations298.41351.77382.12737.42977.85517.21955.61935.192316.372482.472668.11
Working Capital Changes-222.95-202.95-338.39-243.54-556.2915.34-214.82-1268.12-1300.05457.02-1224.59
Taxes paid-25.98-43.35-38.85-147.5-176.99-28.5-115.86-339.04-425.91-482.29-529.97
Cash from Investing Activity-605-12-302-408-569-534-295-401-624-1,542-981
Fixed Assets Purchased-180.94-132.56-289.45-341.88-516.49-401.19-165.79-148.65-544-1019.6-975.77
Fixed Assets Sold15.531.681.0117.792.760.511.6510.312.042.09255.6
Investments purchased-320.13-85.22-69.27-73.13-200.19-153.2900-197.54-540.75-257.35
Investments sold0170.9748.17038.81023.320028.710
Cash from Financing Activity723-185161-14443-78-229-3135-1,329440
Proceeds from Shares2.851.5305.441.0800.823.456.766.660.23
Proceeds from Borrowings73.990443.52180.31622.061112.88287.18101.39377.510990.62
Repayment of Borrowings-163.7-112.58-48.12-107.88-89.8-148.7-352.34-7.03-110.3-1156.54-237.79
Interest Paid-77.21-58.68-55.4-56.36-32.98-68.17-97.63-69.7-58.91-41.93-49.24
Dividends Paid-9.12-15.72-39.31-28.83-47.47-33.82-67.43-59.55-152.7-113.95-219.4
Net Cash Flow168-92-136-75118-108101-1051-414372

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %12%14%7%21%20%9%15%29%27%24%20%19%
Debtor Days122128147132131122116153168175143159
Inventory Turnover4.013.803.963.803.743.454.094.524.184.003.953.52

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Aurobindo Pharma Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.